Table 3.
Adherence with Five Quality Indicators Used in the Composite Quality Score of Guideline Adherence by Co-Morbid Condition for 1,240 Ambulatory Post-AMI Patients in the MI-Plus Study
| Condition (total N = 1,240) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Hypertension | Hyperlipidemia | Diabetes | Current smoker | Chronic obstructive pulmonary disease | Depression | Obesity | Chronic kidney disease | Chronic heart failure | |
| n = 879 | n = 730 | n = 445 | n = 128 | n = 289 | n = 158 | n = 273 | n = 134 | n = 345 | |
| Guideline concordance indicator | |||||||||
| Aspirin prescribed at discharge | 76% | 83% | 75% | 74% | 73% | 71% | 72% | 71% | 74% |
| Beta blockers prescribed at discharge | 63% | 65% | 65% | 56% | 52% | 54% | 58% | 68% | 68% |
| Lipid-lowering agent prescribed at discharge | 75% | 88% | 80% | 66% | 63% | 73% | 78% | 74% | 69% |
| ACE inhibitors prescribed at discharge among diabetic patients | 74% | 76% | 74% | 73% | 71% | 62% | 77% | 67% | 78% |
| ACE inhibitors prescribed at discharge among patients with chronic heart failure | 75% | 72% | 67% | 86% | 71% | 69% | 80% | 61% | 72% |